SE429338B - Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan - Google Patents

Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan

Info

Publication number
SE429338B
SE429338B SE7708621A SE7708621A SE429338B SE 429338 B SE429338 B SE 429338B SE 7708621 A SE7708621 A SE 7708621A SE 7708621 A SE7708621 A SE 7708621A SE 429338 B SE429338 B SE 429338B
Authority
SE
Sweden
Prior art keywords
benzylpyrrolidines
substituted
procedure
preparation
therapeutic effect
Prior art date
Application number
SE7708621A
Other languages
English (en)
Swedish (sv)
Other versions
SE7708621L (sv
Inventor
K Eistetter
H Schaefer
H G Menge
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of SE7708621L publication Critical patent/SE7708621L/xx
Publication of SE429338B publication Critical patent/SE429338B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7708621A 1976-07-28 1977-07-27 Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan SE429338B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75478A LU75478A1 (de) 1976-07-28 1976-07-28

Publications (2)

Publication Number Publication Date
SE7708621L SE7708621L (sv) 1978-01-29
SE429338B true SE429338B (sv) 1983-08-29

Family

ID=19728311

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7708621A SE429338B (sv) 1976-07-28 1977-07-27 Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan

Country Status (23)

Country Link
US (1) US4279918A (de)
JP (1) JPS5315367A (de)
AT (1) AT373580B (de)
AU (1) AU509015B2 (de)
BE (1) BE857289A (de)
CA (1) CA1104572A (de)
CH (1) CH639368A5 (de)
DE (2) DE2733817A1 (de)
DK (1) DK339677A (de)
ES (1) ES461077A1 (de)
FR (1) FR2359823A1 (de)
GB (1) GB1566761A (de)
GR (1) GR61367B (de)
IE (1) IE45320B1 (de)
IL (1) IL52611A (de)
IT (1) IT1085949B (de)
LU (1) LU75478A1 (de)
NL (1) NL7708306A (de)
NZ (1) NZ184755A (de)
PT (1) PT66858B (de)
SE (1) SE429338B (de)
YU (1) YU184277A (de)
ZA (1) ZA774553B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
DE2952382A1 (de) * 1979-12-24 1981-07-16 Basf Ag, 6700 Ludwigshafen Phenylpropylammoniumsalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4826869A (en) * 1988-02-19 1989-05-02 Syntex (U.S.A.) Inc. N-(lower alkyl)-2-(3'ureidobenzyl)pyrrolidines
US5100912A (en) * 1990-05-14 1992-03-31 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidine) derivatives as dopamine agonists
US5135944A (en) * 1989-06-21 1992-08-04 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidine) derivatives useful for treating congestive heart failure and acute renal failure
EP0404115A1 (de) * 1989-06-21 1990-12-27 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidin)-Derivate als Dopamin-Agonisten
US5093355A (en) * 1989-10-30 1992-03-03 Syntex (U.S.A.) Inc. Benzylpyrrolidine derivatives as dopamine agonists
US5130432A (en) * 1990-12-21 1992-07-14 Syntex (U.S.A.) Inc. Process for preparing cyclic amines and intermediate products thereof
EP0562185A1 (de) * 1992-03-17 1993-09-29 Council of Scientific and Industrial Research 3-(Arylmethyl)-1-(3'-diethylaminopropyl)-pyrrolidine und Verfahren zu ihrer Herstellung
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US7208517B1 (en) * 1994-08-19 2007-04-24 Abbott Labortories Endothelin antagonists
CN104292143A (zh) * 2014-08-17 2015-01-21 湖南华腾制药有限公司 一种2-(4-溴苄基)吡咯烷的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049380B (de) * 1959-01-29 Bergisch Gladbach Adolf Christian Josef Opfermann Verfahren zur Herstellung von a-substituierten Pyrrolidinen
FR86099E (fr) 1963-08-20 1965-12-03 Pechiney Saint Gobain Dérivés de la delta1-pyrroline
DE1470387A1 (de) 1963-12-20 1969-05-29 Union Carbide Corp Verfahren zur Herstellung von substituierten Pyrrolderivaten
GB1168797A (en) 1965-12-09 1969-10-29 Nat Res Dev Cyclopropane Carboxylic Acid Derivatives and their use as Insecticides
US3647790A (en) * 1969-04-08 1972-03-07 American Home Prod Ouinoxalinyl-oxazolidines and -oxazines

Also Published As

Publication number Publication date
ES461077A1 (es) 1978-12-01
GR61367B (en) 1978-10-30
SE7708621L (sv) 1978-01-29
DK339677A (da) 1978-01-29
AT373580B (de) 1984-02-10
BE857289A (fr) 1978-01-30
IT1085949B (it) 1985-05-28
NL7708306A (nl) 1978-01-31
NZ184755A (en) 1979-12-11
IL52611A0 (en) 1977-10-31
FR2359823B1 (de) 1980-11-21
LU75478A1 (de) 1978-02-08
IE45320B1 (en) 1982-07-28
US4279918A (en) 1981-07-21
CA1104572A (en) 1981-07-07
YU184277A (en) 1983-02-28
DE2733817A1 (de) 1978-02-02
GB1566761A (en) 1980-05-08
AU509015B2 (en) 1980-04-17
IL52611A (en) 1981-10-30
ZA774553B (en) 1978-06-28
CH639368A5 (de) 1983-11-15
IE45320L (en) 1978-01-28
PT66858B (de) 1979-03-13
DE2733753A1 (de) 1978-02-02
FR2359823A1 (fr) 1978-02-24
AU2736577A (en) 1979-02-01
JPS5315367A (en) 1978-02-13
ATA548177A (de) 1983-06-15
PT66858A (de) 1977-08-01

Similar Documents

Publication Publication Date Title
SE434395B (sv) Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE7805591L (sv) Forfarande for framstellning av aminoalkylbensen-derivat med farmaceutisk verkan
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE7804736L (sv) Forfarande for framstellning av isoindolinderivat med terapeutisk verkan
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE440907B (sv) Forfarande for framstellning av imidazolderivat med farmaceutisk verkan
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan
SE7800930L (sv) Forfarande for framstellning av bensensulfonamid- och bensenkarboxamidderivat med terapeutisk verkan
SE7514308L (sv) Forfarande for framstellning av tyrosinderivat med terapeutisk verkan
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE7712219L (sv) Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan
SE7805105L (sv) Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan
SE7708521L (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE417712B (sv) Forfarande for framstellning av n-(6-acyloxibensotiazol-2-yl)-nŸ-fenylkarbamider med terapeutisk verkan
SE7712217L (sv) Forfarande for framstellning av dekahydrocyklopent-(c)azepiner med terapeutisk verkan
SE7606236L (sv) Forfarande for framstellning av piperazinforeningar med terapeutisk verkan
SE7609420L (sv) Forfarande for framstellning av karbonylsubstituerade 1-sulfonylbensimidazoler med terapeutisk verkan